Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: A comparison between transgenic mouse models and human patients

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 3, 2013, Pages 177-189

  Saris, Christiaan G J ^a   Groen, Ewout J N ^a   Koekkoek, Johan A F ^a   Veldink, Jan H ^a   Van Den Berg, Leonard H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

RNA; SOD1; Transgenic animals; Ubiquintin

Indexed keywords

CATHEPSIN B; CATHEPSIN D; GLIAL FIBRILLARY ACIDIC PROTEIN; METAL ION; PROTEASOME; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; GENE EXPRESSION PROFILING; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RESPONSE; LYSOSOME; META ANALYSIS; MITOCHONDRION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN METABOLISM; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC;

EID: 84875740460     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2012.729842     Document Type: Article

References (47)

1. Malaspina A, Kaushik N, de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem. 2001; 77: 132-45.
2. Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch M, Stephanopoulos G, et al. Molecular signature of late-stage human ALS revealed by expression profiling of post mortem spinal cord grey matter. Physiol Genomics. 2004; 16: 229-39.
3. Jiang Y, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, Terao S, et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol. 2005; 57: 236-51.
4. Wang X, Simmons Z, Liu W, Boyer P, Connor J. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph Lateral Scler. 2006; 7: 201-16.
5. Lederer C, Torrisi A, Pantelidou M, Santama N, Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics. 2007; 8: 26.
6. Offen D, Barhum Y, Melamed E, Embacher N, Schindler C, Ransmayr G. Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant. J Mol Neurosci. 2008.
7. Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo S-W, et al. Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011: 1-12.
8. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, Takeuchi H, et al. Differential expression of inflammation-and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 2002; 80: 158-67.
9. Olsen MK, Roberds SL, Ellerbrock BR, Fleck TJ, Mckinley DK, Gurney ME. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol. 2002; 50: 730-40.
10. Perrin F, Boisset G, Docquier M, Schaad O, Descombes P, Kato A. No widespread induction of cell death genes occurs in pure motor neurons in an amyotrophic lateral sclerosis mouse model. Hum Mol Genet. 2005; 14: 3309-20.
11. Perrin F, Boisset G, Lathuiliere A, Kato A. Cell death pathways differ in several mouse models with motor neuron disease: analysis of pure motor neuron populations at a presymptomatic age. J Neurochem. 2006; 98: 1959-72.
12. Fukada Y, Yasui K, Kitayama M, Doi K, Nakano T, Watanabe Y, et al. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res. 2007; 1160: 1-10.
13. Ferraiuolo L, Heath PR, Holden H, Kasher P, Kirby J, Shaw PJ. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1-G93A mouse model of familial ALS. J Neurosci. 2007; 27: 9201-19.
14. D'arrigo A, Colavito D, Peña-Altamira E, Fabris M, Dam M, Contestabile A, et al. Transcriptional Profiling in the Lumbar Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis: A Role for Wild-Type Superoxide Dis-mutase 1 in Sporadic Disease? J Mol Neurosci. 2010: 1-12.
15. Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, Valdmanis P, et al. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Human Molecular Genetics. 2010; 19: 3233-53.
16. Chen H, Guo Y, Hu M, Duan W, Chang G, Li C. Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model. Brain Research. 2010;1340: 1-60.
17. Rosen D, Siddique T, Patterson D, Figlewicz D, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 362: 59-62.
18. Ishigaki S, Niwa J, Ando Y, Yoshihara T, Sawada K, Doyu M, et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords: screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett. 2002; 531: 354-8.
19. Lincecum JM, Vieira FG, Wang MZ, Thompson K, de Zutter GS, Kidd J, et al. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet. 2010; 42: 392-9.
20. Lobsiger CS, Boillée S, Cleveland DW Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci USA. 2007; 104: 7319-26.
21. Vargas MR, Pehar M, Díaz-Amarilla PJ, Beckman JS, Barbeito L. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J Neurosci Res. 2008; 86: 3515-25.
22. Kirby J, Halligan E, Baptista MJ, Allen S, Heath PR, Holden H, et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain. 2005; 128: 1686-706.
23. Lincecum JM, Vieira FG, Wang MZ, Thompson K, de Zutter GS, Kidd J, et al. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet. 2010; 42: 392-9.
24. Saris CGJ, Horvath S, van Vught PWJ, van Es MA, Blauw HM, Fuller TF, et al. Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. BMC Genomics. 2009; 10: 405.
25. Gonzalez de Aguilar J, Niederhauser-Wiederkehr C, Halter B, de Tapia M, Di Scala F, Demougin P, et al. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics. 2008; 32: 207-18.
26. Bendotti C, Marino M, Cheroni C, Fontana E, Crippa V, Poletti A, et al. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog Neurobiol. 2011;97:101-26.
27. Deng H-X, Chen W, Hong S-T, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011; 477: 211-5.
28. Nakamura M, Kaneko S, Wate R, Asayama S, Nakamura Y, Fujita K, et al. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology. 2012
29. Morris HR, Waite AJ, Williams NM, Neal JW, Blake DJ. Recent Advances in the Genetics of the ALS-FTLD Complex. Curr Neurol Neurosci Rep. 2012; DOI: 10.1111/j.1365-2990.2012.01270.x.
30. Ottervald J, Franzén B, Nilsson K, Andersson LI, Khademi M, Eriksson B, et al. Multiple sclerosis: identi fication and clinical evaluation of novel CSF biomarkers. J Proteomics. 2010; 73: 1117-32.
31. Chou SM, Taniguchi A, Wang HS, Festoff BW Serpin = &z.ast; serine protease-like complexes within neurofilament conglomerates of motor neurons in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 1998; 160 (Suppl 1): S73-9.
32. Glas M, Popp B, Angele B, Koedel U, Chahli C, Schmalix WA, et al. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Experimental Neurology. 2007; 207: 350-6.
33. Ince PG, Evans J, Knopp M, Forster G, Hamdalla HHM, Wharton SB, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003; 60: 1252-8.
34. Leigh PN, Abrahams S, Al-Chalabi A, Ampong M-A, Goldstein LH, Johnson J, et al. The management of motor neuron disease. Journal of Neurology, Neurosurgery & Psychiatry. 2003; 74 (Suppl 4): 32-47.
35. van den Berg-Vos RM, Visser J, Franssen H, de Visser M, de Jong JMBV, Kalmijn S, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain. 2003; 126: 1036-47.
36. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science. 1996; 274: 998-1001.
37. Bergemalm D, Forsberg K, Jonsson P, Graffmo K, Brännström T, Andersen P, et al. Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis. Mol Cell Proteomics. 2009;8:1306-17.
38. Raoul C, Estévez AG, Nishimune H, Cleveland DW, de Lapeyrière O, Henderson CE, et al. Motor neuron death triggered by a specific pathway downstream of Fas potentiation by ALS-linked SOD1 mutations. Neuron. 2002; 35: 1067-83.
39. Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, Stewart C, et al. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem. 2002; 82: 365-74.
40. Tang HL, Lung HL, Wu KC, Le A-HP, Tang HM, Fung MC. Vimentin supports mitochondrial morphology and organization. Biochem J. 2008; 410: 141-6.
41. Perlson E, Hanz S, Ben-Yaakov K, Segal-Ruder Y, Seger R, Fainzilber M. Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron. 2005; 45: 715-26.
42. Grewal RP, Morgan TE, Finch CE. C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci Lett. 1999; 271: 65-7.
43. Olsen MK, Roberds SL, Ellerbrock BR, Fleck TJ, McKinley DK, Gurney ME. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol. 2001; 50: 730-40.
44. Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, et al. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem Biophys Res Commun. 2006; 342: 1034-9.
45. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol. 2007; 44: 999-1010.
46. Fonseca MI, Kawas CH, Troncoso JC, Tenner AJ. Neuronal localization of C1q in preclinical Alzheimer's disease. Neurobiol Dis. 2004; 15: 40-6.
47. Gasque P, Dean YD, McGreal EP, van Beek J, Morgan BP Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology. 2000; 49: 171-86.